tiprankstipranks
Advertisement
Advertisement
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany AnnouncementsNoxopharm Issues 15 Million New Shares Under Financing Facility
2M ago
Noxopharm Issues 15 Million New Shares Under Financing Facility
Premium
Company Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
2M ago
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
Premium
Company Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
2M ago
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
PremiumCompany AnnouncementsNoxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
4M ago
Noxopharm Issues New Unquoted Options and Convertible Notes
Premium
Company Announcements
Noxopharm Issues New Unquoted Options and Convertible Notes
4M ago
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
Premium
Company Announcements
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
4M ago
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
PremiumCompany AnnouncementsNoxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
5M ago
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
Premium
Company Announcements
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
5M ago
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
Premium
Company Announcements
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100